MHS
GYRE icon

M Holdings Securities’s Gyre Therapeutics GYRE Stock Holding History

M Holdings Securities’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$369K Sell
11,360
-1,200
-10% -$41.2K 0.04% 207
2021
Q1 		$475K Sell
12,560
-4,467
-26% -$204K 0.04% 299
2020
Q4 		$806K Buy
17,027
+27
+0.2% +$1.17K 0.1% 133
2020
Q3 		$548K Sell
17,000
-2,660
-14% -$104K 0.09% 135
2020
Q2 		$866K Buy
+19,660
New +$923K 0.15% 120

Other funds holding GYRE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

M Holdings Securities's GYRE Position: Q2 2021 in Review

M Holdings Securities reduced its Gyre Therapeutics (GYRE) stake by 9.6% in Q2 2021, selling an estimated $41.2K and leaving 11,360 shares worth $369K. The position accounts for 0.04% of the portfolio, ranked #207.

M Holdings Securities first reported a position in GYRE in Q2 2020 and has held it in 5 quarters since. The position peaked at $866K in Q2 2020. 69 funds tracked by Wall St. Rank hold GYRE as of Q2 2021.

  • M Holdings Securities held 11,360 shares of Gyre Therapeutics worth $369K as of Q2 2021.
  • M Holdings Securities sold 1,200 Gyre Therapeutics shares in Q2 2021, an estimated $41.2K.
  • Gyre Therapeutics made up 0.04% of M Holdings Securities's portfolio in Q2 2021, its #207 holding.
  • M Holdings Securities first reported a position in Gyre Therapeutics in Q2 2020 and has held it in 5 quarters since.
  • M Holdings Securities's Gyre Therapeutics position peaked at $866K in Q2 2020.
  • 69 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2021.

Based on M Holdings Securities's 13F filing for Q2 2021, filed 19 Aug 2021.